REQUEST A DEMO
Total
USD $0.00
Search more companies

Chong Kun Dang Pharmaceutical Corp. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Chong Kun Dang Pharmaceutical Corp. Profile Updated: September 01, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English Download a sample report

Chong Kun Dang Pharmaceutical Corp. is engaged in manufacturing and selling of medicines. The company offers products such as prescription drugs for anti-hypertension, anti-hyperlipidemia, anti-diabetics, anticancer, and immunosuppressant; health supplements, including prebiotics complex Prelacto and Premium Omega-3+vitamin; and healthy beverage products. In addition, Chong Kun Dang Pharmaceutical Corp. also provides over-the-counter drugs, such as Penzal for headache; Zelcom for antithelmintic; Prefemine for premenstrual syndrome. The company was founded in 2013 and is headquartered in Seoul, South Korea.

Headquarters
8, Chungjeong-ro Seodaemun-gu Seoul
Seoul; Seoul;

Contact Details: Purchase the Chong Kun Dang Pharmaceutical Corp. report to view the information.

Website: http://chongkundang.en.ec21.com/

Basic Information
Total Employees:
Purchase the Chong Kun Dang Pharmaceutical Corp. report to view the information.
Outstanding Shares:
Purchase the Chong Kun Dang Pharmaceutical Corp. report to view the information.
Registered Capital:
Purchase the Chong Kun Dang Pharmaceutical Corp. report to view the information.
Ratings:
Purchase the Chong Kun Dang Pharmaceutical Corp. report to view the information.
Incorporation Date:
November 05, 2013
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
22.5%
Purchase this report to view the information.
12.3%
Purchase this report to view the information.
9.5%
Subsidiaries
Company Performance
Financial values in the chart are available after Chong Kun Dang Pharmaceutical Corp. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
5.21%
Total operating revenue
5.21%
Operating profit (EBIT)
-10.1%
EBITDA
-6.63%
Net Profit (Loss) for the Period
-9.64%
Total assets
7.04%
Total equity
11.66%
Operating Profit Margin (ROS)
-1.49%
Net Profit Margin
-1%
Return on Equity (ROE)
-1.63%
Debt to Equity Ratio
-7.63%
Quick Ratio
-0.08%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?